Lavinia Life Sciences Profile
Key Indicators
- Authorised Capital ₹ 1.00 Cr
as on 16-12-2024
- Paid Up Capital ₹ 1.00 Cr
as on 16-12-2024
- Company Age 6 Year, 20 Days
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 9.75 Cr
as on 16-12-2024
- Revenue 4310.62%
(FY 2022)
- Profit -608.76%
(FY 2022)
- Ebitda -139.53%
(FY 2022)
- Net Worth -87.86%
(FY 2022)
- Total Assets 33.07%
(FY 2022)
About Lavinia Life Sciences
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 1.00 Cr and a paid-up capital of Rs 1.00 Cr.
The company currently has active open charges totaling ₹9.75 Cr.
Vijaykumar Nair, Sandip Mhatre, Shyam Nair, and One other member serve as directors at the Company.
- CIN/LLPIN
U74999MH2018PTC317722
- Company No.
317722
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
30 Nov 2018
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Company Details
- LocationNavi Mumbai, Maharashtra
- Telephone
- Email Address
- Website
- Social Media-
Who are the key members and board of directors at Lavinia Life Sciences?
Board Members(4)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Vijaykumar Nair  | Director | 30-Nov-2018 | Current |
| Sandip Mhatre | Director | 03-Jan-2020 | Current |
| Shyam Nair | Director | 30-Nov-2018 | Current |
| Neelam Mhatre | Director | 03-Jan-2020 | Current |
Financial Performance and Corporate Structure Insights of Lavinia Life Sciences.
Lavinia Life Sciences Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 4310.62% increase. The company also saw a substantial fall in profitability, with a 608.76% decrease in profit. The company's net worth observed a substantial decline by a decrease of 87.86%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Lavinia Life Sciences?
In 2023, Lavinia Life Sciences had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Thermolab Scientific Equipments Private LimitedActive 29 years 2 monthsSandip Mhatre and Neelam Mhatre are mutual person
Thermolab Healthcare Private LimitedActive 13 years 5 monthsSandip Mhatre and Neelam Mhatre are mutual person
- Thermolab Sales And Services Private LimitedActive 23 years 11 months
Sandip Mhatre and Neelam Mhatre are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Others Creation Date: 24 Dec 2020 | ₹5.25 Cr | Open |
Others Creation Date: 24 Dec 2020 | ₹4.50 Cr | Open |
How Many Employees Work at Lavinia Life Sciences?
Unlock and access historical data on people associated with Lavinia Life Sciences, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Lavinia Life Sciences, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Lavinia Life Sciences's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
